XOFLX™ Stable Technology: a Simplified High- Yielding LVV Manufacturing System that Lowers Costs & Improves Process Consistency
Time: 1:00 pm
day: Day 1 - Track C - AM
Details:
- WuXi Advanced Therapies is dedicated to supporting our cell therapy partners throughout their path to clinic and patient care
- Our innovative XOFLX™ (pronounced So-flex) stable technology was developed to meet the industry need for large quantities of high-quality lentiviral vectors (LVV) with demonstrated safety and efficacy
- By reducing or eliminating the requirement for plasmid input materials, our XOFLX™ technology cuts the cost of LVV production and improves process robustness
